Skip to main content
. 2019 Feb 21;17:52. doi: 10.1186/s12967-019-1803-9

Fig. 1.

Fig. 1

Representative CT scanning result of one patient with acquired MET amplification who responded to crizotinib monotherapy. a Before treatment; b partial response was detected after 1 month of treatment